These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 25779322)
21. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis. de Steenwinkel JE; de Knegt GJ; ten Kate MT; van Belkum A; Verbrugh HA; Kremer K; van Soolingen D; Bakker-Woudenberg IA J Antimicrob Chemother; 2010 Dec; 65(12):2582-9. PubMed ID: 20947621 [TBL] [Abstract][Full Text] [Related]
22. Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase. Khan SR; Singh S; Roy KK; Akhtar MS; Saxena AK; Krishnan MY Int J Antimicrob Agents; 2013 Jan; 41(1):41-6. PubMed ID: 23141113 [TBL] [Abstract][Full Text] [Related]
23. [Some aspects of determination of the sensitivity of Mycobacterium tuberculosis to ethambutol using a semiliquid medium]. Manicheva OA Probl Tuberk Bolezn Legk; 2003; (10):47-9. PubMed ID: 14669632 [TBL] [Abstract][Full Text] [Related]
24. The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment. Honeyborne I; Mtafya B; Phillips PP; Hoelscher M; Ntinginya EN; Kohlenberg A; Rachow A; Rojas-Ponce G; McHugh TD; Heinrich N; J Clin Microbiol; 2014 Aug; 52(8):3064-7. PubMed ID: 24871215 [TBL] [Abstract][Full Text] [Related]
28. Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis. Early J; Ollinger J; Darby C; Alling T; Mullen S; Casey A; Gold B; Ochoada J; Wiernicki T; Masquelin T; Nathan C; Hipskind PA; Parish T ACS Infect Dis; 2019 Feb; 5(2):272-280. PubMed ID: 30501173 [TBL] [Abstract][Full Text] [Related]
29. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis. Foroumadi A; Soltani F; Moshafi MH Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384 [TBL] [Abstract][Full Text] [Related]
30. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis. Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240 [TBL] [Abstract][Full Text] [Related]
31. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains. Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124 [TBL] [Abstract][Full Text] [Related]
33. A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis. Gold B; Warrier T; Nathan C Methods Mol Biol; 2015; 1285():293-315. PubMed ID: 25779324 [TBL] [Abstract][Full Text] [Related]
35. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens. Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754 [TBL] [Abstract][Full Text] [Related]
36. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis. Heifets LB; Lindholm-Levy PJ; Iseman MD Am Rev Respir Dis; 1988 Mar; 137(3):719-21. PubMed ID: 2830815 [TBL] [Abstract][Full Text] [Related]